or misrepresentation or equivocal conduct which might have led Lipscomb to believe he was entering the infirmary for medical treatment. Once Lipscomb had been admitted to the infirmary for examination, it was obviously beneficial to all concerned to have the examining physician also minister to his ailments. Such medical treatment in no way altered the purpose of Lipscomb's admission nor did it extend the scope of the examination into areas not authorized by the statute. Whether the doctor merely examines the subject, or examines and treats him, the doctor will only testify at the commitment hearing to matters relevant to the primary purpose of the examination. [3] Significantly, the new Evidence Code in section 1004 specifically excepts examinations for commitment from the doctor-patient privilege: "There is no privilegeCodeine methylbromide

Codeine methylbromide (Eucodin) is the bromomethane (methylbromide) salt of codeine. Its possession is prohibited in many jurisdictions. It is considered a Schedule I controlled substance in the United States, with a DEA ACSCN of 9070 and nil annual aggregate manufacturing quota. as of 2014.  As it is used in a different way than basic salts of codeine like the phosphate or hydrochloride owing to its below-mentioned dual action, it is considered to be a different drug related to codeine rather than merely a salt of it in many contexts.

Also known by the genericised trade name eucodeine, and the salt name also sometimes given as methobromide, this drug was first synthesised in Austria-Hungary in 1903.  As it is a bromide in addition to a codeine salt,